Alnylam Pharmaceuticals Stock Forecast
Alnylam Pharmaceuticals stock downgraded from Hold/Accumulate to Sell Candidate after Wednesday trading session.
(Updated on Apr 24, 2024)
The Alnylam Pharmaceuticals stock price fell by -1.55% on the last day (Wednesday, 24th Apr 2024) from $146.07 to $143.80. During the last trading day the stock fluctuated 2.76% from a day low at $143.52 to a day high of $147.49. The price has fallen in 8 of the last 10 days and is down by -5.65% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -165 thousand shares and in total, 368 thousand shares were bought and sold for approximately $52.87 million.
The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $143.09, a level that may pose a second chance to hit a runner. According to fan-theory $160.27 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ALNY Signals & Forecast
There are few to no technical positive signals at the moment. The Alnylam Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $145.32 and $149.32. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 22, 2024, and so far it has fallen -11.68%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Alnylam Pharmaceuticals stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $3.97 (2.76%) between high and low. For the last week, the stock has had daily average volatility of 2.52%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ALNY) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Alnylam Pharmaceuticals to open at $144.94, and during the day (based on 14 day Average True Range), to move between $139.90 and $147.70, which gives a possible trading interval of +/-$3.90 (+/-2.71%) up or down from last closing price. If Alnylam Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.43% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $147.00, some $3.20 (2.23%) from the current price of $143.80, our system finds the risk reward not very attractive.
Earnings coming up
Alnylam Pharmaceuticals will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.750. We will update the financials statements for Alnylam Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.73% in the first trading day after earnings release.
Is Alnylam Pharmaceuticals stock A Buy?
Alnylam Pharmaceuticals holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -3.664 Sell Candidate Downgraded
Predicted Opening Price for Alnylam Pharmaceuticals of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $144.94 ( 0.790%) | $143.80 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ALNY
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 148.90 | 3.55 % | |
| R2 | 147.39 | 2.49 % | ||
| R1 | 146.45 | 1.84 % | ||
| Current price: | 143.80 | |||
| Support | S1 | 143.42 | -0.264 % | |
| S2 | 142.48 | -0.91 % | ||
| S3 | 140.97 | -1.97 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 154.74 | 7.61 % | |
| R2 | 147.43 | 2.52 % | ||
| R1 | 147.00 | 2.23 % | ||
| Current price | 143.80 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Alnylam Pharmaceuticals Stock.
